Search research articles
Contact Us
Filters
Showing results (31-40 of 184) with videos related to
Page
of 19
Sort By:
The Journal of Clinical Investigation
|
November 1, 1984
Nonenzymatic addition of glucocorticoids to lens proteins in steroid-induced cataracts
S Manabe, R Bucala, A Cerami
Biotherapy (Dordrecht, Netherlands)
|
January 1, 1994
The emerging role of MIF in septic shock and infection
J Bernhagen, T Calandra, R Bucala
Immunology and Cell Biology
|
August 8, 2001
Neuroendocrine properties of macrophage migration inhibitory factor (MIF)
G R Fingerle-Rowson, R Bucala
The Journal of Clinical Investigation
|
September 1, 1992
Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus
M Hogan, A Cerami, R Bucala
Biochemistry
|
January 17, 1995
Identification of N2-(1-carboxyethyl)guanine (CEG) as a guanine advanced glycosylation end product
A Papoulis, Y al-Abed, R Bucala
The Journal of Clinical Investigation
|
February 1, 1991
Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes
R Bucala, K J Tracey, A Cerami
Proceedings of the National Academy of Sciences of the United States of America
|
June 10, 1997
The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ
J Chesney, M Bacher, A Bender, et al.
Diabetes/Metabolism Research and Reviews
|
July 9, 1999
A role for the endocrine and pro-inflammatory mediator MIF in the control of insulin secretion during stress
G Waeber, T Calandra, C Bonny, et al.
The Journal of Experimental Medicine
|
March 1, 1991
Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts
R Bucala, C Ritchlin, R Winchester, et al.
The Journal of Biological Chemistry
|
March 15, 1992
Immunochemical detection of advanced glycosylation end products in vivo
Z Makita, H Vlassara, A Cerami, et al.
Page
of 19
Search research articles
Search
Showing results (31-40 of 184) with videos related to
Sort By:
Page
of 19
The Journal of Clinical Investigation
|
November 1, 1984
Nonenzymatic addition of glucocorticoids to lens proteins in steroid-induced cataracts
S Manabe, R Bucala, A Cerami
Biotherapy (Dordrecht, Netherlands)
|
January 1, 1994
The emerging role of MIF in septic shock and infection
J Bernhagen, T Calandra, R Bucala
Immunology and Cell Biology
|
August 8, 2001
Neuroendocrine properties of macrophage migration inhibitory factor (MIF)
G R Fingerle-Rowson, R Bucala
The Journal of Clinical Investigation
|
September 1, 1992
Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus
M Hogan, A Cerami, R Bucala
Biochemistry
|
January 17, 1995
Identification of N2-(1-carboxyethyl)guanine (CEG) as a guanine advanced glycosylation end product
A Papoulis, Y al-Abed, R Bucala
The Journal of Clinical Investigation
|
February 1, 1991
Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes
R Bucala, K J Tracey, A Cerami
Proceedings of the National Academy of Sciences of the United States of America
|
June 10, 1997
The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ
J Chesney, M Bacher, A Bender, et al.
Diabetes/Metabolism Research and Reviews
|
July 9, 1999
A role for the endocrine and pro-inflammatory mediator MIF in the control of insulin secretion during stress
G Waeber, T Calandra, C Bonny, et al.
The Journal of Experimental Medicine
|
March 1, 1991
Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts
R Bucala, C Ritchlin, R Winchester, et al.
The Journal of Biological Chemistry
|
March 15, 1992
Immunochemical detection of advanced glycosylation end products in vivo
Z Makita, H Vlassara, A Cerami, et al.
Page
of 19